Skip to search formSkip to main contentSkip to account menu

168 HR Clonidine 0.00833 MG/HR Transdermal System

Known as: CLONIDINE 0.2 mg in 1 d TRANSDERMAL PATCH [Clonidine], cloNIDine HCl 0.2 MG/Day Weekly Transdermal System, Clonidine 0.2 mg in 1 d TRANSDERMAL PATCH 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
OBJECTIVE To explore the efficacy, safety, and tolerability of once-weekly efpeglenatide, a long-acting glucagon-like peptide 1… 
2014
2014
The current investigation sought to determine whether a standard outpatient dose of dialectical behavior therapy (DBT) skills… 
2007
2007
A33 Background: VEGFR-2 is a key regulator of angiogenesis and cancer cell growth. IMC-1121B is a recombinant human IgG1 MAb… 
2006
2006
Background: We wished to define the maximum tolerated dose (MTD), toxicity, and pharmacokinetics of the novel isoflav-3-ene, NV06… 
Highly Cited
2005
Highly Cited
2005
In view of the recent interest in weekly erythropoietic regimens and the lack of studies directly comparing the available agents… 
2004
2004
3031 Background: 17AAG is a benzoquinone antibiotic known to down regulate oncoproteins, by binding to heat shock protein 90… 
Highly Cited
2001
Highly Cited
2001
In this study, the processes affecting sea surface temperature variability over the 1992-98 period, encompassing the very strong…